About the Authors
- Simon R. Stockwell
-
Contributed equally to this work with: Simon R. Stockwell, Georgina Platt
Affiliations Research Department of Cancer Biology, UCL Cancer Institute, London, United Kingdom, Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom
- Georgina Platt
-
Contributed equally to this work with: Simon R. Stockwell, Georgina Platt
Affiliation Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom
- S. Elaine Barrie
-
Affiliation Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom
- Georgia Zoumpoulidou
-
Affiliations Research Department of Cancer Biology, UCL Cancer Institute, London, United Kingdom, Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom
- Robert H. te Poele
-
Affiliation Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom
- G. Wynne Aherne
-
Affiliation Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom
- Stuart C. Wilson
-
Affiliation Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom
- Peter Sheldrake
-
Affiliation Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom
- Edward McDonald
-
Affiliation Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom
- Mathilde Venet
-
Affiliation Cancer Research Technology Discovery Laboratories London, Wolfson Institute for Biomedical Research, London, United Kingdom
- Christelle Soudy
-
Affiliation Cancer Research Technology Discovery Laboratories London, Wolfson Institute for Biomedical Research, London, United Kingdom
- Frédéric Elustondo
-
Affiliation Cancer Research Technology Discovery Laboratories London, Wolfson Institute for Biomedical Research, London, United Kingdom
- Laurent Rigoreau
-
Affiliation Cancer Research Technology Discovery Laboratories London, Wolfson Institute for Biomedical Research, London, United Kingdom
- Julian Blagg
-
Affiliation Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom
- Paul Workman
-
Affiliation Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom
- Michelle D. Garrett
-
Affiliation Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, Sutton, United Kingdom
- Sibylle Mittnacht
-
* E-mail: s.mittnacht@cancer.ucl.ac.uk
Affiliations Research Department of Cancer Biology, UCL Cancer Institute, London, United Kingdom, Division of Cancer Biology, The Institute of Cancer Research, London, United Kingdom
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: SS GP GWA SM. Performed the experiments: SS GP SEB GZ RHtP GWA SCW. Analyzed the data: SS GP GWA SEB RHtP. Contributed reagents/materials/analysis tools: SCW MV CS FE MV CS FE LR. Wrote the paper: SM. Discussion, technical advice: EM JB PW MG LR PS.